Delivery Order SPE2DB20D9329-SPE2DB25FZK67
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,531.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,291.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with an ultimate completion date of July 8, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency issued a delivery order on July 26, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Exparel 266 mg/20 ml vials. The contract is valued at $2,510.63 on a firm fixed-price basis with an ultimate completion date of August 15, 2025. This delivery order was awarded without a set-aside designation, leveraging the vendor's competitive positioning as a small business in the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,427.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period through July 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 21, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management. The contract carries no set-aside designation, and DMS Pharmaceutical Group is competing as a small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,855.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This is a $29,846.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. The delivery order has an ultimate completion date of September 24, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK67Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the vendor to compete on its merits as a certified woman-owned small business in the federal pharmaceutical procurement marketplace. This delivery order is executed under DMS Pharmaceutical Group's significant $499.999 billion indefinite delivery contract with the Defense Logistics Agency's SPE2DB program, which remains valid through November 2026. The contract vehicle enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. EXPAREL, a liposomal bupivacaine injectable anesthetic, represents one of the specialized pharmaceutical products routinely ordered through this framework to support Department of Defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 7/30/25 |